0 Comentários
0 Compartilhamentos
175 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Regional Analysis of the Tremfya MarketThe rising burden of chronic inflammatory and autoimmune disorders has significantly increased demand for targeted biologic therapies. Among these, Tremfya (guselkumab) has emerged as a leading treatment option for moderate-to-severe plaque psoriasis and psoriatic arthritis. Strong Tremfya drug market growth, expanding guselkumab market applications, and increasing demand within...0 Comentários 0 Compartilhamentos 389 Visualizações 0 Anterior
-
Tremfya Market Opportunities and Challenges for Pharmaceutical StakeholdersTremfya (guselkumab), developed by Johnson & Johnson, is a monoclonal antibody that selectively targets the p19 subunit of interleukin-23. Polaris Market Research values the Tremfya market at USD 4.2 billion in 2025, with a projected CAGR of 7.40% from 2026 to 2034 and USD 7.99 billion by 2034. This article focuses on how label expansion, access support, and competition are shaping the...0 Comentários 0 Compartilhamentos 206 Visualizações 0 Anterior
-
Tremfya Market: Key Developments Transforming Patient CareAccording to a new report by Polaris Market Research, the global Tremfya market was valued at USD 4.2 billion in 2025 and is projected to reach USD 7.99 billion by 2034, expanding at a CAGR of 7.40% over the forecast period. Growth is underpinned by rising adoption of biologic therapies, expanding regulatory approvals across inflammatory indications, and accelerating investment in...0 Comentários 0 Compartilhamentos 208 Visualizações 0 Anterior
-
Tremfya Market: Opportunities and Competitive LandscapeThe Tremfya market was valued at USD 4.2 billion in 2025 and is projected to reach USD 7.99 billion by 2034, growing at a CAGR of 7.40% from 2026 to 2034, according to Polaris Market Research. Several factors support this growth: a rising preference for biologic therapies over traditional systemic treatments, higher healthcare spending, and better access to specialty medicines. Tremfya...0 Comentários 0 Compartilhamentos 3 Visualizações 0 Anterior
-
U.S. Tremfya Market Forecast to Witness Steady Growth During 2025–2034The U.S. Tremfya Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, U.S. Tremfya Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and future potential to provide a...0 Comentários 0 Compartilhamentos 211 Visualizações 0 Anterior